Combination Therapy With Ruxolitinib and Ibrutinib Reduces the Severity of Murine Sclerodermatous Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Imbruvica (ibrutinib) - AbbVie, J&J

Jakafi (ruxolitinib) - Incyte

https://www.sciencedirect.com/science/article/abs/pii/S2152265026032064

Vasantharaja Raguraman PhD 1; Shanid Mohiyuddin PhD 1; Sahra Gabure 1; Nashwan Jabbour MD 2; Melissa Kesler MD 2; Senthilnathan Palaniyandi PhD 1; Gerhard Hildebrandt MD,FACP 1

Sep 1, 2026